Apr 14, 2024, 06:47
Hagop Youssoufian: I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics
Hagop Youssoufian,
Youssoufian Consulting, LLC, posted on LinkedIn:“I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics, which is aspiring to develop revolutionary CAR T therapies for a highly lethal form of thyroid cancer as well as lung cancer.”
View the article attached to the post.
Source: Hagop Youssoufian/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34